Abstract 7286: A first-in-class αPD-1/αVEGF/IL-2v tri-specific fusion protein demonstrates promising anti-tumor efficacy in immune checkpoint inhibitor-resistant tumor models
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Sunjung Cho, Jun-Eui Park, Yongjun Jung, Hyojoo Bang, Jeongseok Heo, Seokchan Kang, Suna Kim, Minwoo Kim, Young Jin Park
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409632133